|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wu YL and Zhou Q: Clinical trials and
biomarker research on lung cancer in China. Expert Opin Ther
Targets. 16(Suppl 1): S45–S50. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dykxhoorn DM: MicroRNAs and metastasis:
little RNAs go a long way. Cancer Res. 70:6401–6406. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Garzon R, Fabbri M, Cimmino A, Calin GA
and Croce CM: MicroRNA expression and function in cancer. Trends
Mol Med. 12:580–587. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar
|
|
7
|
Li W, Wang Y, Zhang Q, Tang L, Liu X, Dai
Y, Xiao L, Huang S, Chen L, Guo Z, Lu J and Yuan K: MicroRNA-486 as
a biomarker for early diagnosis and recurrence of non-small cell
lung cancer. PLoS One. 10:e01342202015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mavridis K, Gueugnon F, Petit-Courty A,
Courty Y, Barascu A, Guyetant S and Scorilas A: The oncomiR miR-197
is a novel prognostic indicator for non-small cell lung cancer
patients. Br J Cancer. 112:1527–1535. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tejero R, Navarro A, Campayo M, Viñolas N,
Marrades RM, Cordeiro A, Ruíz-Martínez M, Santasusagna S, Molins L,
Ramirez J and Monzó M: miR-141 and miR-200c as markers of overall
survival in early stage non-small cell lung cancer adenocarcinoma.
PLoS One. 9:e1018992014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Patnaik SK, Mallick R and Yendamuri S:
Detection of microRNAs in dried serum blots. Anal Biochem.
407:147–149. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang X, Zeng Z, Hou Y, Yuan T, Gao C, Jia
W, Yi X and Liu M: MicroRNA-92a as a potential biomarker in
diagnosis of colorectal cancer: a systematic review and
meta-analysis. PLoS One. 9:e887452014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shen J, Hruby GW, McKiernan JM, Gurvich I,
Lipsky MJ, Benson MC and Santella RM: Dysregulation of circulating
microRNAs and prediction of aggressive prostate cancer. Prostate.
72:1469–1477. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ng EK, Li R, Shin VY, Jin HC, Leung CP, Ma
ES, Pang R, Chua D, Chu KM, Law WL, et al: Circulating microRNAs as
specific biomarkers for breast cancer detection. PLoS One.
8:e531412013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gorur A, Balci Fidanci S, Dogruer Unal N,
Ayaz L, Akbayir S, Yildirim Yaroglu H, Dirlik M, Serin MS and Tamer
L: Determination of plasma microRNA for early detection of gastric
cancer. Mol Biol Rep. 40:2091–2096. 2013. View Article : Google Scholar
|
|
16
|
Zhang B, Yin Y, Hu Y, Zhang J, Bian Z,
Song M, Hua D and Huang Z: MicroRNA-204-5p inhibits gastric cancer
cell proliferation by downregulating USP47 and RAB22A. Med Oncol.
32:3312015. View Article : Google Scholar
|
|
17
|
Li W, Jin X, Zhang Q, Zhang G, Deng X and
Ma L: Decreased expression of miR-204 is associated with poor
prognosis in patients with breast cancer. Int J Clin Exp Pathol.
7:3287–3292. 2014.PubMed/NCBI
|
|
18
|
Munari E, Marchionni L, Chitre A, Hayashi
M, Martignoni G, Brunelli M, Gobbo S, Argani P, Allaf M, Hoque MO
and Netto GJ: Clear cell papillary renal cell carcinoma: micro-RNA
expression profiling and comparison with clear cell renal cell
carcinoma and papillary renal cell carcinoma. Hum Pathol.
45:1130–1138. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shi L, Zhang B, Sun X, Lu S, Liu Z, Liu Y,
Li H, Wang L, Wang X and Zhao C: MiR-204 inhibits human NSCLC
metastasis through suppression of NUAK1. Br J Cancer.
111:2316–2327. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Imam JS, Plyler JR, Bansal H, Prajapati S,
Bansal S, Rebeles J, Chen HI, Chang YF, Panneerdoss S, Zoghi B, et
al: Genomic loss of tumor suppressor miRNA-204 promotes cancer cell
migration and invasion by activating AKT/mTOR/Rac1 signaling and
actin reorganization. PLoS One. 7:e523972012. View Article : Google Scholar
|
|
21
|
Yin Y, Zhang B, Wang W, Fei B, Quan C,
Zhang J, Song M, Bian Z, Wang Q, Ni S, et al: miR-204-5p inhibits
proliferation and invasion and enhances chemotherapeutic
sensitivity of colorectal cancer cells by downregulating RAB22A.
Clin Cancer Res. 20:6187–6199. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu X, Zeng Y, Wu S, Zhong J, Wang Y and Xu
J: MiR-204, down-regulated in retinoblastoma, regulates
proliferation and invasion of human retinoblastoma cells by
targeting CyclinD2 and MMP-9. FEBS Lett. 589:645–650. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li G, Luna C, Qiu J, Epstein DL and
Gonzalez P: Role of miR-204 in the regulation of apoptosis,
endoplasmic reticulum stress response, and inflammation in human
trabecular meshwork cells. Invest Ophthalmol Vis Sci. 52:2999–3007.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
25
|
Niklinski J, Furman M, Laudanski J and
Kozlowski M: Prognostic value of pretreatment CEA, SCC-Ag and CA
19-9 levels in sera of patients with non-small cell lung cancer.
Eur J Cancer Prev. 1:401–406. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ruopp MD, Perkins NJ, Whitcomb BW and
Schisterman EF: Youden Index and optimal cut-point estimated from
observations affected by a lower limit of detection. Biom J.
50:419–430. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schwarzenbach H, Nishida N, Calin GA and
Pantel K: Clinical relevance of circulating cell-free microRNAs in
cancer. Nat Rev Clin Oncol. 11:145–156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kang K, Peng X, Luo J and Gou D:
Identification of circulating miRNA biomarkers based on global
quantitative real-time PCR profiling. J Anim Sci Biotechnol.
3:42012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang J, Zhang KY, Liu SM and Sen S:
Tumor-associated circulating microRNAs as biomarkers of cancer.
Molecules. 19:1912–1938. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cortez MA, Bueso-Ramos C, Ferdin J,
Lopez-Berestein G, Sood AK and Calin GA: MicroRNAs in body fluids -
the mix of hormones and biomarkers. Nat Rev Clin Oncol. 8:467–477.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jia W, Wu Y, Zhang Q, Gao G, Zhang C and
Xiang Y: Identification of four serum microRNAs from a genome-wide
serum microRNA expression profile as potential non-invasive
biomarkers for endometrioid endometrial cancer. Oncol Lett.
6:261–267. 2013.PubMed/NCBI
|
|
32
|
Wang Y, Li W, Zang X, Chen N, Liu T,
Tsonis PA and Huang Y: MicroRNA-204-5p regulates
epithelial-to-mesenchymal transition during human posterior capsule
opacification by targeting SMAD4. Invest Ophthalmol Vis Sci.
54:323–332. 2013. View Article : Google Scholar
|
|
33
|
Zhou X, Li L, Su J and Zhang G: Decreased
miR-204 in H pylori- associated gastric cancer promotes cancer cell
proliferation and invasion by targeting SOX4. PLoS One.
9:e1014572014. View Article : Google Scholar
|
|
34
|
Xia Y, Zhu Y, Ma T, Pan C, Wang J, He Z,
Li Z, Qi X and Chen Y: miR-204 functions as a tumor suppressor by
regulating SIX1 in NSCLC. FEBS Lett. 588:3703–3712. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ma L, Deng X, Wu M, Zhang G and Huang J:
Down-regulation of miRNA-204 by LMP-1 enhances CDC42 activity and
facilitates invasion of EBV-associated nasopharyngeal carcinoma
cells. FEBS Lett. 588:1562–1570. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bao W, Wang HH, Tian FJ, He XY, Qiu MT,
Wang JY, Zhang HJ, Wang LH and Wan XP: A TrkB-STAT3-miR-204-5p
regulatory circuitry controls proliferation and invasion of
endometrial carcinoma cells. Mol Cancer. 12:1552013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ryan J, Tivnan A, Fay J, Bryan K, Meehan
M, Creevey L, Lynch J, Bray IM, O'Meara A, Tracey L, et al:
MicroRNA-204 increases sensitivity of neuroblastoma cells to
cisplatin and is associated with a favourable clinical outcome. Br
J Cancer. 107:967–976. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sacconi A, Biagioni F, Canu V, Mori F, Di
Benedetto A, Lorenzon L, Ercolani C, Di Agostino S, Cambria AM,
Germoni S, et al: miR-204 targets Bcl-2 expression and enhances
responsiveness of gastric cancer. Cell Death Dis. 3:e4232012.
View Article : Google Scholar : PubMed/NCBI
|
